IMPAACT P1058A: Pharmacokinetic Effects of New Antiretroviral Drugs on Children, Adolescents and Young Adults
Status:
Completed
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
This study will examine drug and body interactions in children receiving anti-HIV treatment
regimens using new medications. Drug regimens to be examined will feature the medications
raltegravir (RAL), maraviroc (MVC), and etravirine (ETV). These drugs will not be provided
through the study.
Details
Lead Sponsor:
International Maternal Pediatric Adolescent AIDS Clinical Trials Group
Collaborator:
National Institute of Allergy and Infectious Diseases (NIAID)